It generally takes as long as 17 years for hospitals and clinics to implement a practice or treatment after the first evidence shows a benefit in patients. This time lag is driven by a number of factors, including building ...
Apr 4, 2022
0
7
A new study in JAMA co-authored by a University of Rochester Medical Center (URMC) researcher has found that the survival rates of extremely pre-term babies has increased significantly in the past decade.
Apr 1, 2022
0
26
Delirium is a serious change in brain function that affects up to 64% of older medical patients and up to 50% of older surgical patients. It can manifest as sudden confusion, agitation, memory loss or hallucinations and delusions. ...
Mar 31, 2022
0
17
Plastic surgeons play an key as consultants in complex reconstructive surgery cases—providing a major contribution to the bottom line for academic medical centers, concludes an analysis in the April issue of Plastic and ...
Mar 31, 2022
0
2
Patients who undergo facial surgery think their surgical scars look worse than surgeons and independent observers do, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Surgeons ...
Mar 16, 2022
0
16
Women who are obese and struggling to become pregnant are often advised to lose weight, but a new study finds no fertility benefits from weight loss.
Mar 14, 2022
0
41
A new study—in mice—from Washington University School of Medicine in St. Louis suggests that blocking a major inflammatory pathway that is activated in pancreatic cancer makes the tumors sensitive to chemotherapy and ...
Mar 7, 2022
0
49
The survival rate of extremely preterm infants born from 2013 through 2018 in a large network of U.S. research centers improved to 78.3 percent, compared to 76 percent for infants born in the network from 2008 to 2012, according ...
Jan 19, 2022
0
4
(HealthDay)—Pregnant people with sickle cell trait (SCT) have increased risk of stillbirth, according to a study published online Nov. 24 in JAMA Network Open.
Dec 3, 2021
0
2
The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons ...
Nov 30, 2021
0
3
